1. AB0079 Transdermal delivery of methotrexate in rheumatoid arthritis: are we deep enough?. (15th June 2017) Authors: Sadarani, B; Majumdar, A; Kamble, P; Paradkar, S; Mathur, A; Sachdev, S; Chaudhari, P; Mohanty, B Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1074 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP48 Use of biologic therapies with different mechanisms of action (MOA) in the first-line (1L) treatment of Crohn's Disease (CD) in the U.S. (27th May 2021) Authors: Huang, Z; Ba, Y; Kamble, P; Wang, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP60 Simplified rules to identify bio-naïve patients with Crohn's Disease with higher likelihood of clinical remission when initiating vedolizumab versus anti-TNFα therapies: Analysis of EVOLVE study data. (27th May 2021) Authors: Mantzaris, G; Yarur, A; Wang, S; Adsul, S; Kamble, P; Luo, M; Guerin, A; Billmyer, E; Nguyen, H; Bressler, B Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S095 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effects of the COVID-19 pandemic on delivery of emergency surgical care in India. Issue 4 (1st February 2021) Authors: Bhandoria, G; Gadgil, A; Khajanchi, M; Sarang, B; Kizhakke Veetil, D; Wadhawan, R; Bhandarkar, P; Mohan, M; Shah, P; Bains, L; Mishra, A; Arora, S; Rattan, A; Kant, R; Sharma, N; Bhavishi, D; Satoskar, R R; Prajapati, R; Srivastava, K S; Kamble, P Journal: British journal of surgery Issue: Volume 108:Issue 4(2021) Page Start: e154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P267 Sequencing of anti-TNF agents and gut-selective anti-lymphocyte trafficking (GSALT) therapy in the treatment of Crohn's disease (CD). (27th May 2021) Authors: Huang, Z; Ba, Y; Kamble, P; Wang, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P636 Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naïve patients with Crohn's disease: Results from the EVOLVE Expansion study. (30th January 2023) Authors: Ferrante, M; Christensen, B; Bressler, B; Brett, N; Bassel, M; Kamble, P; Adsul, S; Gianchetti, L; Scharl, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i768 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P703 Real world experience of the transition from the intravenous to subcutaneous formulation of vedolizumab in inflammatory bowel disease: A review of current data. (30th January 2023) Authors: Agboton, C; Kamble, P Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i835 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗